ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Kinnate Biopharma Inc

Kinnate Biopharma Inc (KNTE)

2.65
0.00
(0.00%)
Closed July 17 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.65
Bid
2.64
Ask
2.65
Volume
-
0.00 Day's Range 0.00
1.04 52 Week Range 3.31
Previous Close
2.65
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

KNTE Latest News

XOMA Corporation Announces Closing of Tender Offer

EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech...

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the “Company”; Nasdaq: XOMA) entered into a merger agreement to...

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories PR Newswire CASTRES, France and SAN FRANCISCO, March 1, 2024 Kinnate has entered into...

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories

Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.The transaction is in furtherance...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260.187.287449392712.472.692.24250752.54854062CS
52-0.43-13.9610389613.083.311.046576892.42317509CS
156-18.73-87.605238540721.3826.051.043241605.67391929CS
260-37.35-93.3754048.751.042993488.96443421CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SILOSilo Pharma Inc
$ 2.38
(122.43%)
176.27M
TKLFYoshitsu Company Ltd
$ 0.6117
(99.74%)
318.35M
NAASNaaS Technology Inc
$ 4.6301
(65.36%)
22.46M
ATGLAlpha Technology Group Limited
$ 4.18
(47.18%)
920.43k
LCFYLocafy Ltd
$ 5.34
(46.30%)
6.5M
JEWLAdamas One Corporation
$ 0.33
(-25.88%)
275.38k
AEHLAntelope Enterprise Holdings Ltd
$ 4.04
(-21.86%)
488.93k
AMIXAutonomix Medical Inc
$ 1.09
(-21.01%)
6.99M
ASLNASLAN Pharmaceuticals Ltd
$ 1.10
(-20.29%)
599.54k
CYNCYNGN Inc
$ 7.3799
(-19.61%)
1.16M
TKLFYoshitsu Company Ltd
$ 0.6117
(99.74%)
318.35M
MAXNMaxeon Solar Technologies Ltd
$ 0.2524
(11.19%)
246.61M
NVDANVIDIA Corporation
$ 126.36
(-1.62%)
214.79M
SILOSilo Pharma Inc
$ 2.38
(122.43%)
176.27M
SQQQProShares UltraPro Short QQQ
$ 7.46
(0.00%)
130.15M